Kiniksa Pharmaceuticals International, plc Increase (Decrease) in Inventories
Kiniksa Pharmaceuticals International, plc (KNSA) reported Increase (Decrease) in Inventories of $18.25 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-04-28
- Kiniksa Pharmaceuticals International, plc increase (decrease) in inventories for the quarter ending 2026-03-31 was $18.25M.
- Kiniksa Pharmaceuticals International, plc increase (decrease) in inventories for the quarter ending 2025-12-31 was $13.50M.
- Kiniksa Pharmaceuticals International, plc increase (decrease) in inventories for the quarter ending 2025-09-30 was -$6.79M.
- Kiniksa Pharmaceuticals International, plc increase (decrease) in inventories for the quarter ending 2025-06-30 was $26.11M, a 244.49% increase year-over-year.
- Kiniksa Pharmaceuticals International, plc increase (decrease) in inventories for fiscal 2025 was $28.53M.
- Kiniksa Pharmaceuticals International, plc increase (decrease) in inventories for fiscal 2024 was -$4.76M, a 149.96% decline from fiscal 2023.
- Kiniksa Pharmaceuticals International, plc increase (decrease) in inventories for fiscal 2023 was $9.52M, a 46.87% decline from fiscal 2022.
- Kiniksa Pharmaceuticals International, plc increase (decrease) in inventories for fiscal 2022 was $17.92M, a 387.73% increase from fiscal 2021.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2026-03-31 | $18.25M 10-Q · filed 2026-04-28 | $31.75M derived: sum of 2 quarters · filed 2026-04-28 | $24.96M derived: sum of 3 quarters · filed 2026-04-28 | $51.07M derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-12-31 | $13.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $6.71M derived: sum of 2 quarters · filed 2026-02-24 | $32.83M derived: sum of 3 quarters · filed 2026-02-24 | $28.53M 10-K · filed 2026-02-24 |
| 2025-09-30 | -$6.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $19.33M derived: sum of 2 quarters · filed 2025-10-28 | $15.03M 10-Q · filed 2025-10-28 | $12.72M derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-06-30 | $26.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $21.82M 10-Q · filed 2025-07-29 | $19.50M derived: sum of 3 quarters · filed 2026-04-28 | $13.32M derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-03-31 | -$4.29M 10-Q · filed 2026-04-28 | -$6.61M derived: sum of 2 quarters · filed 2026-04-28 | -$12.79M derived: sum of 3 quarters · filed 2026-04-28 | -$5.21M derived: sum of 4 quarters · filed 2026-04-28 |
| 2024-12-31 | -$2.32M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$8.49M derived: sum of 2 quarters · filed 2026-02-24 | -$914.00K derived: sum of 3 quarters · filed 2026-02-24 | -$4.76M 10-K · filed 2026-02-24 |
| 2024-09-30 | -$6.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $1.40M derived: sum of 2 quarters · filed 2025-10-28 | -$2.44M 10-Q · filed 2025-10-28 | $3.10M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $7.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $3.74M 10-Q · filed 2025-07-29 | $9.28M derived: sum of 3 quarters · filed 2026-02-24 | $10.90M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | -$3.84M 10-Q · filed 2025-04-29 | $1.70M derived: sum of 2 quarters · filed 2026-02-24 | $3.32M derived: sum of 3 quarters · filed 2026-02-24 | $3.85M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $5.54M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $7.16M derived: sum of 2 quarters · filed 2026-02-24 | $7.70M derived: sum of 3 quarters · filed 2026-02-24 | $9.52M 10-K · filed 2026-02-24 |
| 2023-09-30 | $1.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $2.16M derived: sum of 2 quarters · filed 2024-10-29 | $3.98M 10-Q · filed 2024-10-29 | $10.96M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $533.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-25 | $2.36M 10-Q · filed 2024-07-25 | $9.34M derived: sum of 3 quarters · filed 2025-02-25 | $4.04M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $1.83M 10-Q · filed 2024-04-25 | $8.80M derived: sum of 2 quarters · filed 2025-02-25 | $3.51M derived: sum of 3 quarters · filed 2025-02-25 | $10.20M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $6.98M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $1.68M derived: sum of 2 quarters · filed 2025-02-25 | $8.38M derived: sum of 3 quarters · filed 2025-02-25 | $17.92M 10-K · filed 2025-02-25 |
| 2022-09-30 | -$5.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $1.40M derived: sum of 2 quarters · filed 2023-11-02 | $10.95M 10-Q · filed 2023-11-02 | $9.02M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $6.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $16.24M 10-Q · filed 2023-08-01 | $14.31M derived: sum of 3 quarters · filed 2024-02-28 | $13.54M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $9.55M 10-Q · filed 2023-05-04 | $7.62M derived: sum of 2 quarters · filed 2024-02-28 | $6.84M derived: sum of 3 quarters · filed 2024-02-28 | |
| 2021-12-31 | -$1.93M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$2.71M derived: sum of 2 quarters · filed 2024-02-28 | $3.67M 10-K · filed 2024-02-28 | |
| 2021-09-30 | -$775.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $5.61M 10-Q · filed 2022-11-03 | ||
| 2021-06-30 | $6.38M 10-Q · filed 2022-08-04 |